Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: Correlation with disease activity

Journal of Rheumatology

Volumn 23, Issue 6, 1996, Pages 974-978

  Emlen, Woodruff ^a,b   Niebur, Joann ^a,c   Flanders, Gretchen ^a,c   Rutledge, James ^a,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Department of Medicine ^*  (United States)

^c UNITED STATES AIR FORCE ACADEMY   (United States)

Author keywords

C REACTIVE PROTEIN; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; HYALURONIC ACID; RHEUMATOID ARTHRITIS

Indexed keywords

C REACTIVE PROTEIN; HYALURONIC ACID;

ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYALURONIC ACID; MALE; MIDDLE AGED; PROGNOSIS;

EID: 0030004293     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
2. Felson DT, ACR Committee on Outcome Measures in RA Trials: American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
3. Smith MM, Ghosh P: The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 1987;7:113-22.
4. Hamerman D, Wood DD: Interleukin 1 enhances synovial cell hyaluronate synthesis. Proc Soc Exp Biol Med 1984;117:205-10.
5. Butler DM, Vitti GF, Leizer T, Hamilton JA: Stimulation of the hyaluronic acid levels of human synovial fibroblasts by recombinant human tumor necrosis factor α, tumor necrosis factor β (lymphotoxin), interleukin-1α, and interleukin-1β. Arthritis Rheum 1988;31:1281-9.
6. Sisson JC, Castor CW, Klavons JA: Connective tissue activation. XVIII. Stimulation of hyaluronic acid synthetase activity. J Lab Clin Med 1980;96:189-94.
7. Dahl LB, Dahl IM, Engström-Laurent A, Granath K: Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985;44:817-22.
8. Balazs EA, Watson D, Duff IF, Roseman S: Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum 1967;10:357-64.
9. Eriksson S, Fraser JRE, Laurent TC, Pertoft H, Smedsrod B: Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res 1983;144:223-8.
10. Fraser JRE, Nyberg A, Laurent TC: Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis. J Lab Clin Med 1986;107:79-85.
11. Fribourg T, Delpech B, Bercoff E, et al: Serum hyaluronate in liver diseases: Study by enzymoimmunological assay. Hepatology 1986;6:392-5.
12. Engström-Laurent A, Loof L, Nyberg A, Schroder T: Increased serum levels of hyaluronate in liver disease. Hepatology 1985;5:638-42.
13. Björk J, Kleinau S, Tengblad A, Smedegard G: Elevated levels of serum hyaluronate and correlation with disease activity in experimental models of arthritis. Arthritis Rheum 1959;32:306-11.
14. Goldberg RL, Rubin AS: Hyaluronate as a marker for disease severity in Lactobacillus casei model of arthritis in the rat. J Rheumatol 1989;16:92-6.
15. Goldberg RL, Huff JP, Lenz ME, Glickman P, Katz R, Thonar EJ-MA: Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1991;34:799-807.
16. Poole AR, Witter J, Roberts N, et al: Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum 1990;33:790-9.
17. Santos ME, Kondo T, Wieczorek A, Lopez LR: Increased serum hyaluronic acid levels in rheumatoid arthritis (abstr). Arthritis Rheum 1994;37:S247
18. Laurent TC, Dahl IM, Dahl LB, et al: The catabolic fate of hyaluronic acid. Connective Tissue Res 1986;15:33-41.
19. Konttinen YT, Saari H, Honkanen VEA, et al: Serum baseline hyaluronate and disease activity in rheumatoid arthritis. Clinica Chimica Acta 1990;193:39-48.
20. Engström-Laurent A, Hällgren R: Circulating hyaluronate in rheumatoid arthritis: Relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 1985;44:83-8.
21. Paimela L, Heiskanen A, Kurki P, Helve T, Leirisalo-Repo M: Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritis. Arthritis Rheum 1991;34:815-21.
22. Chichibu K, Matsuura T, Shichijo S, Yokoyama MM: Assay of serum hyaluronic acid in clinical application. Clinica Chimica Acta 1989;181:317-24.
23. Lindqvist U, Chichibu K, Delpech B, et al: Seven different assays of hyaluronan compared for clinical utility. Clinical Chemistry 1992;38:127-32.
24. Yoshinoya S, Mizoguchi Y, Hashimoto Y, et al: Serum concentration of hyaluronic acid in healthy populations and patients with rheumatoid arthritis - relationship to clinical disease activity of RA. Ryumachi 1991;31:381-90.
25. Engström-Laurent A, Hällgren R: Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients. Arthritis Rheum 1987;30:1333-8.
26. Mallya RK, deBeer FC, Berry H, Hamilton EDB, Mace BEW, Pepys MB: Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J Rheumatol 1982;9:224-8.
27. Cush JJ, Lipsky PE, Postlethwaite AE, Schrohenloher RE, Saway A, Koopman WJ: Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal anti-inflammatory drug therapy in rheumatoid arthritis. Arthritis Rheum 1990;33:19-28.